Another database (gepia.cancer-pku.cn) also showed that the overall survival rate of malignant melanoma patients tended to be lower in the group with high TMEM16A expression (n = 229) than in the group with low TMEM16A expression (n = 229). This evidence concerns the gene ANO1 and melanoma.